| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/23/2006 | US20060040324 Methods for making metallopeptides and metallopeptide libraries |
| 02/23/2006 | US20060040313 Human chemokine beta-9 |
| 02/23/2006 | US20060040307 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 02/23/2006 | US20060040269 Cytotoxic factors for modulating cell death |
| 02/23/2006 | US20060040266 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2) |
| 02/23/2006 | US20060040265 Regulation of novel human asparagine-hydroxylases |
| 02/23/2006 | US20060040262 Novel compositions and methods in cancer |
| 02/23/2006 | US20060039927 Specific binding agents for KSHV vIL-6 that neutralize a biological activity |
| 02/23/2006 | US20060039918 Stress proteins and peptides and methods of use thereof |
| 02/23/2006 | US20060039915 P-cadherin as a target for anti-cancer therapy |
| 02/23/2006 | DE20023745U1 Method of modulating expression of an endogenous cellular gene in a cell to prevent gene activation or prevent repression of gene expression comprising contacting a target sequence with a zinc finger protein |
| 02/23/2006 | DE102004040452A1 Peptidgemisch Peptide mixture |
| 02/23/2006 | DE102004039280A1 1,5-Diphenyl-pyrazole 1,5-diphenyl-pyrazoles |
| 02/23/2006 | CA2777686A1 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 02/23/2006 | CA2777473A1 Compounds and methods for the treatment of cancer |
| 02/23/2006 | CA2583700A1 Quinone prodrug compositions and methods of use |
| 02/23/2006 | CA2579764A1 Methods of regulating differentiation and treating of multiple myeloma |
| 02/23/2006 | CA2579449A1 Galenic applications of self-emulsifying mixtures of lipidic excipients |
| 02/23/2006 | CA2578280A1 Arene ruthenium (ii) compounds and their use in cancer therapy |
| 02/23/2006 | CA2578098A1 Hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl) benzamide, methods for the production thereof, and use thereof as medicaments |
| 02/23/2006 | CA2577880A1 Compounds useful for inhibiting chk1 |
| 02/23/2006 | CA2577692A1 Methods and compositions for treatment of hematologic cancers |
| 02/23/2006 | CA2577448A1 Androgen modulators |
| 02/23/2006 | CA2577368A1 Improved anticancer treatment |
| 02/23/2006 | CA2577213A1 Use of gsk-3 inhibitors for the treatment of prostate cancer |
| 02/23/2006 | CA2577135A1 Deuterium depleted water (ddw) using as adjuvant in cancer therapy for cytostatics toxicity reduction |
| 02/23/2006 | CA2577036A1 Small interfering rna molecules against ribonucleotide reductase and uses thereof |
| 02/23/2006 | CA2576619A1 Benzothienopyridines for use as inhibitors of eg5 kinesin |
| 02/23/2006 | CA2576531A1 1,5-diphenylpyrazoles |
| 02/23/2006 | CA2575821A1 Dihydropteridinone infusion solution having a long shelf life |
| 02/23/2006 | CA2575787A1 Dihydropteridinones for the treatment of cancer diseases |
| 02/23/2006 | CA2575367A1 3-halo-2-oxopropionate salts and esters as novel anticancer agents |
| 02/23/2006 | CA2575188A1 Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer |
| 02/23/2006 | CA2575056A1 Selected fused heterocyclics and uses thereof |
| 02/23/2006 | CA2573761A1 Use of estrogen related receptor-modulating aryl ethers |
| 02/23/2006 | CA2573720A1 Netrin-related compositions and uses |
| 02/23/2006 | CA2573262A1 Conjugates of a gm-csf moiety and a polymer |
| 02/22/2006 | EP1627916A1 Anti-bambi antibody and diagnostic or remedy for colon cancer and liver cancer containing the same |
| 02/22/2006 | EP1627880A1 Boronic ester and acid compounds, synthesis and uses |
| 02/22/2006 | EP1627871A1 Cyclic aminophenyl sulfamate derivative |
| 02/22/2006 | EP1627645A1 Antitumor agent and process for producing the same |
| 02/22/2006 | EP1627640A1 Sulfate group transferase inhibitor |
| 02/22/2006 | EP1626991A2 Anti alpha-folate-receptor-tetramer antibodies |
| 02/22/2006 | EP1626974A2 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 02/22/2006 | EP1626719A1 Pharmaceutical composition containing histone deacetylase inhibitor |
| 02/22/2006 | EP1626711A2 Compositions and methods for treating cancer |
| 02/22/2006 | EP1434882A4 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes |
| 02/22/2006 | EP1414812B1 Hydroxamic acid derivatives |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1384472B1 Method for producing an organic solvent-free lycopene concentrate, the resulting concentrate and composition comprising said concentrate |
| 02/22/2006 | EP1320300B1 Food supplement |
| 02/22/2006 | EP1244805B1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 02/22/2006 | EP1237545B1 Use of stearidonic acid in the manufacture of a medicament for the treatment or prevention of cancer |
| 02/22/2006 | EP1208086B1 Benzamide formulation with histone deacetylase inhibitor activity |
| 02/22/2006 | EP1194584B1 Method for producing oligopolysaccharides |
| 02/22/2006 | EP1121156B1 Polymer conjugates of interferon beta- 1a and their uses |
| 02/22/2006 | EP1062336B1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 02/22/2006 | EP1047788B1 Method of determining metastatic potential employing the asp1 gene |
| 02/22/2006 | EP1001781B1 Use of taurolidine or taurultam for the manufacture of a medicament for the prevention of metastases |
| 02/22/2006 | EP0957929B1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/22/2006 | EP0805871B2 Anti-cd30 antibodies preventing proteolytic cleavage and release of membrane-bound cd30 antigen |
| 02/22/2006 | CN1739030A Diagnosis and prevention of cancer cell invasion |
| 02/22/2006 | CN1738829A New 2',5'-oligoadenylic acid analog |
| 02/22/2006 | CN1738827A Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone |
| 02/22/2006 | CN1738821A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 02/22/2006 | CN1738817A Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same. |
| 02/22/2006 | CN1738806A Oxo-azabicyclic compounds |
| 02/22/2006 | CN1738788A Substituted phenyl naphthalenes as estrogenic agents |
| 02/22/2006 | CN1738636A Use of enzyme inhibitors with aminopeptidase N and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases wit |
| 02/22/2006 | CN1738624A Method of treatment of myocardial infarction |
| 02/22/2006 | CN1738548A Compositions containing coenzyme q10 |
| 02/22/2006 | CN1737113A Novel bacillus named BARB and its uses |
| 02/22/2006 | CN1737111A Antrodia mycelium active substance preparation method and its components |
| 02/22/2006 | CN1737011A Lymphoma specific chimeric monoclonal antibody against HLA-DR10 |
| 02/22/2006 | CN1736994A Azo hetercyle beta-elemene derivative and its preparation method and uses |
| 02/22/2006 | CN1736991A Azo heterocycle beta-elemene piperazine alkyl derivative and its preparation and uses |
| 02/22/2006 | CN1736981A Selective androgen receptor modulators and methods of use thereof |
| 02/22/2006 | CN1736489A Process for preparing nano-granule of albumin |
| 02/22/2006 | CN1736486A Anticancer implantation agent |
| 02/22/2006 | CN1736484A Method for preparing nanometer particle of galactose sodium alginate-polylysine |
| 02/22/2006 | CN1736457A Application of dye yam extract in preparation of anti-tumor medicine |
| 02/22/2006 | CN1736433A Ointment for treating tumor and rheumatic paralysis |
| 02/22/2006 | CN1736382A Compound chlorpromazine |
| 02/22/2006 | CN1736376A Modulation of peroxisome proliferator-activated receptors |
| 02/22/2006 | CN1736374A Application of (R)- flurbiprofenester in pharmacy, injection thereof and method for preparing the same |
| 02/22/2006 | CN1736371A Selective androgen receptor modulators and methods of use thereof |
| 02/22/2006 | CN1736369A Curcumin emulsion, its preparation process and use |
| 02/22/2006 | CN1736365A Method for preparing nanometer particles of galactose hydroxyapatite-polylysine |
| 02/22/2006 | CN1243103C Preparation process of burduck protoglucoside of anti virus and antiptmour natural medicine |
| 02/22/2006 | CN1243100C Method for production of cytosporasp B and the use in preparation of anti-tumor and antifungal medicine |
| 02/22/2006 | CN1243099C Use and obtain of inactivating lumour CHK1 gene anticancer recombined gland virus constituent |
| 02/22/2006 | CN1243025C Germanium enriced gold needle mushroom polysaccharide and its making metehod and use |
| 02/22/2006 | CN1243018C Blood vessel generating inhibitor |
| 02/22/2006 | CN1243017C Tumor suppressor, coded protein and application thereof |
| 02/22/2006 | CN1243014C Adherence peptide specific to tissue of liver cancer obtained through sieve method in vitro, and usage |
| 02/22/2006 | CN1243013C Adherence peptide specific to tissue of liver cancer, in vivo and in vitro combined screen method, and usage |
| 02/22/2006 | CN1243012C Sekolamin saponin compound |
| 02/22/2006 | CN1243005C Process for preparation of taxan derivatives |
| 02/22/2006 | CN1243004C Tricycloacetal lactones ,preparing process and use thereof |
| 02/22/2006 | CN1243000C Tocopherols, tocotrienols, other chroman and side chain dervative and uses thereof |